Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

Clinical trials have shown that AS03-adjuvanted H5N1 and A(H1N1)pdm09 vaccines are highly immunogenic, although with an increased reactogenicity profile relative to non-adjuvanted vaccines in terms of the incidence of common injection site and systemic adverse events (AEs). We evaluated pooled safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaughn, David W, Seifert, Harry, Hepburn, Anne, Dewe, Walthere, Li, Ping, Drame, Mamadou, Cohet, Catherine, Innis, Bruce L, Fries, Louis F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443104/
https://www.ncbi.nlm.nih.gov/pubmed/25483467
http://dx.doi.org/10.4161/21645515.2014.972149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443104/
https://www.ncbi.nlm.nih.gov/pubmed/25483467
http://dx.doi.org/10.4161/21645515.2014.972149

Ejemplares similares